Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSI) EPS (Basic) (2022 - 2025)

TriSalus Life Sciences (TLSI) has 4 years of EPS (Basic) data on record, last reported at -$0.22 in Q4 2025.

  • For Q4 2025, EPS (Basic) rose 42.11% year-over-year to -$0.22; the TTM value through Dec 2025 reached -$1.84, down 40.46%, while the annual FY2025 figure was -$1.84, 40.46% down from the prior year.
  • EPS (Basic) reached -$0.22 in Q4 2025 per TLSI's latest filing, up from -$0.96 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.09 in Q1 2022 and bottomed at -$79.38 in Q4 2022.
  • Average EPS (Basic) over 4 years is -$7.83, with a median of -$0.38 recorded in 2024.
  • Peak YoY movement for EPS (Basic): crashed 44900.0% in 2023, then surged 99.41% in 2024.
  • A 4-year view of EPS (Basic) shows it stood at -$79.38 in 2022, then skyrocketed by 98.68% to -$1.05 in 2023, then surged by 63.81% to -$0.38 in 2024, then surged by 42.11% to -$0.22 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were -$0.22 in Q4 2025, -$0.96 in Q3 2025, and -$0.27 in Q2 2025.